Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] class drugs

4 results

  • aldurazyme - laronidase injection, solution, concentrate

    (Laronidase)
    Genzyme Corporation
    Aldurazyme treats adult and pediatric patients with Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I), and Scheie form MPS I patients with moderate to severe symptoms.
    Medication Details
    Drug Interactions

  • elaprase - idursulfase solution, concentrate

    (Idursulfase)
    Takeda Pharmaceuticals America, Inc.
    Elaprase treats Hunter syndrome (MPS II) in patients 16 months and older. Improves walking capacity in patients 5 years and older; reduces spleen volume in younger patients. Safety and efficacy not established under 16 months.
    Medication Details

  • naglazyme - galsulfase solution

    (Galsulfase)
    Biomarin Pharmaceutical Inc.
    Naglazyme is indicated for patients with Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome), improving walking and stair-climbing capacity.
    Medication Details

  • vimizim - elosulfase alfa injection, solution, concentrate

    (Elosulfase Alfa)
    Biomarin Pharmaceutical Inc.
    Vimizim (elosulfase alfa) is indicated for patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome).
    Medication Details